Specialty pharmaceutical company China Pharma Holdings (NYSE: CPHI) has seen its stock record handsome gains in 2021 so far and in recent days it has also displayed strong momentum.
The stock has managed to record gains of as much as 90% this year so far and last week, it was in focus among investors as well. Last week, the stock came into sharp focus after the company announced its financial results for 2020. It might be a good idea for investors to take a closer look at China Pharma’s performance.
The company generated revenues of as big as $10.9 million for the year, which was exactly the same as it had generated in 2019. However, on the other hand, the gross margin in 2020 was 18% which was considerably higher than the 13.6% that it had generated in 2019. More importantly, the losses from operations narrowed considerably to only $2.6 million. In the prior-year period, the losses from operations came in at $20.4 million.
Biotech, Tech, and Crypto reporter
Anthony Gonzales brings 3 years of experience in helping grassroots, mid-sized organizations and large institutions strengthen their management and resource generating capacities and effectively plan for the future. He is also a mentor and professional advisor to artists working in all disciplines. He is the gold medalist from St. Marco University of Science and Technology in the Bachelors of Financial Management as well.